Kyverna Therapeutics, Inc. (KYTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$5.10
+4.51%
Mkt Cap $301.80M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 May 12, 2026 | — | — | — | -$0.75 | -$0.66 | +12.00% |
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.84 | -$0.80 | +5.33% |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.97 | -$0.85 | +12.37% |
| Q3 2025 Aug 12, 2025 | — | — | — | -$1.00 | -$0.97 | +3.00% |
| Q2 2025 May 13, 2025 | — | — | — | -$1.21 | -$1.03 | +14.88% |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.87 | -$0.88 | -1.15% |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.77 | -$0.80 | -3.90% |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.70 | -$0.67 | +4.29% |
| Q2 2024 May 14, 2024 | — | — | — | -$0.88 | -$1.12 | -27.27% |
| Q1 2024 Feb 8, 2024 | — | — | — | -$3.23 | -$26.86 | -731.58% |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.36 | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.30 | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.43 | — |
| Q4 2022 Dec 31, 2022 | — | $282.00K | — | — | -$0.20 | — |